308.35
+4.69%
Close of 9 Nov 2026, in INR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About India Glycols
Its shares trade on NSE under the ticker INDIAGLYCO.NS. It has been listed since 28 December 1994. In the fiscal year to 31 March 2025, it reported revenue of ₹90.39bn and net income of ₹2.31bn. At that date it held total assets of ₹61.76bn and shareholders' equity of ₹22.56bn.
India Glycols Ltd. operates as a holding company, which engages in the manufacture of industrial chemicals such as green technology based bulk, specialty and performance chemicals and natural gums and industrial gases, ethyl alcohol (Potable) and nutraceuticals. The company is headquartered in Noida, Uttar Pradesh. The firm's segments include Bio-based Specialities and Performance Chemicals, Potable Spirits, and Ennature Biopharma. The Bio-based Specialities and Performance Chemicals segment comprises glycols, specialty chemicals, natural gum and other related goods. The Potable Spirits segment is engaged in the manufacturing and sale of ethyl alcohol (potable). The Ennature Biopharma segment is engaged in the manufacturing and sale of nutraceutical products. The company has a product range that covers a variety of specialties and herbal products, such as nutraceuticals, phytochemicals, biopolymers, mainly Polygalactomannans, industrial gases and liquor. The company serves various industries, such as automotive, detergents, healthcare and food processing, mining, and oil and gas, among others.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Materials
- Industry
- Chemicals
- Listed since
- 28 Dec 1994
- Employees
- 1,284
- Website
- indiaglycols.com ↗
Leadership
Pay as last reported
- Shri. Uma BhartiaExecutive Chairman of the Board, Managing Director, since 2009₹152.5m
- Shri. Rupark SarswatChief Executive Officer₹36.2m
- Shri. Anand SinghalChief Financial Officer₹8.3m
- Shri. Ankur JainCompliance Officer, Company Secretary, Head - Legal₹6.6m
- Ms. Pragya BarwaleWhole-Time Director, since 2020₹60.2m
- Shri. Alok SinghalExecutive Director, since 2023₹9.0m
- Smt. Jayshree BhartiaNon-Executive Director₹1.4m
- Shri. Samrat BanerjeeNon-Executive Independent Director₹1.4m
- Mr. Ravi KumarNon-Executive Independent Director₹2.8m
- Shri. Sushil SalwanNon-Executive Independent Director₹1.3m
- Smt. Shukla WassanNon-Executive Independent Director₹1.5m
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 51
- Environment
- 81
- Social
- 36
- Governance
- 35
- Direct emissions (scope 1)
- 951,135.99 t
- Energy emissions (scope 2)
- 113,923 t
- Women in the workforce
- 2.63952%
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- India Glycols Ltd. manufactures green technology based chemicals and natural gums in Noida, India.
- The company serves automotive, healthcare, and food processing industries with its specialty chemicals.
- Ennature Biopharma segment produces nutraceuticals and phytochemicals for health markets.
Weaknesses
- India Glycols Ltd. has only three business segments limiting diversification.
- The company's product range focuses on chemicals and nutraceuticals without expansion into new markets.
- Noida headquarters may restrict access to global supply chains.
Opportunities
- Growing demand for green technology chemicals in automotive and food processing sectors.
- Expansion into international markets for nutraceuticals and biopolymers.
- Increased adoption of natural gums in detergents and industrial applications.
Threats
- Competition from established chemical manufacturers in the Materials sector.
- Regulatory changes affecting potable alcohol production in India.
- Economic downturns impacting industrial chemical demand.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.